Sage Therapeutics’ (SAGE) “Hold” Rating Reiterated at Needham & Company LLC
Needham & Company LLC restated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report issued on Monday,Benzinga reports. Several other equities analysts have also recently weighed in on SAGE. Wall Street Zen cut Sage Therapeutics from a “hold” rating to a “sell” rating in a report on Saturday, June […]
Needham & Company LLC restated their hold rating on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report issued on Monday,Benzinga reports. Several other equities analysts have also recently weighed in on SAGE. Wall Street Zen cut Sage Therapeutics from a “hold” rating to a “sell” rating in a report on Saturday, June […]
